(Q39165256)

9 September 2017

miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells (English)

1 reference

9 September 2017

1 reference

Chen Zhu

1

1 reference

9 September 2017

Jie Li

2

1 reference

9 September 2017

Gong Cheng

3

1 reference

9 September 2017

Hai Zhou

4

1 reference

9 September 2017

Liangjun Tao

5

1 reference

9 September 2017

Hongzhou Cai

6

1 reference

9 September 2017

Pu Li

7

1 reference

9 September 2017

Qiang Cao

8

1 reference

9 September 2017

Xiaobing Ju

9

1 reference

9 September 2017

Xiaoxin Meng

10

1 reference

9 September 2017

Meilin Wang

11

1 reference

9 September 2017

Zhengdong Zhang

12

1 reference

9 September 2017

Chao Qin

13

1 reference

9 September 2017

Lixin Hua

14

1 reference

9 September 2017

Changjun Yin

15

1 reference

9 September 2017

Pengfei Shao

16

1 reference

9 September 2017

17 April 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

1 reference

9 September 2017

379

1 reference

9 September 2017

1-2

1 reference

9 September 2017

69-75

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1628-4

9 September 2017

0 references

cites work

EMT, the cytoskeleton, and cancer cell invasion

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

MiR-30 family and EMT in human fetal pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

HMGA2 overexpression in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

HMGA2 gene is a promising target for ovarian cancer silencing therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1628-4

HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.

21 January 2018

1 reference

12 December 2020

HMGA2 expression in a canine model of prostate cancer

1 reference

12 December 2020

HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors

1 reference

12 December 2020

HMGIC expression in human adult and fetal tissues and in uterine leiomyomata

1 reference

12 December 2020

miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.

1 reference

12 December 2020

HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases

1 reference

12 December 2020

High level expression of the HMGI (Y) gene during embryonic development.

1 reference

12 December 2020

10.1007/S11010-013-1628-4

Identifiers

DOI

1 reference

9 September 2017

1 reference